Eco R1 Capital, LLC Chinook Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.53 - $26.8 $5.26 Million - $6.55 Million	-244,450 Reduced 35.43%	445,550 $10.3 Million
Q1 2022 May 16, 2022	BUY	$12.02 - $16.69 $8.29 Million - $11.5 Million	690,000 New	690,000 $11.3 Million
Q3 2021 Nov 15, 2021	SELL	$11.5 - $14.86 $10.7 Million - $13.8 Million	-931,650 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.6 - $18.98 $4.33 Million - $6.04 Million	-318,351 Reduced 25.47%	931,650 $13.2 Million
Q4 2020 Feb 16, 2021	BUY	$11.9 - $20.91 $14.9 Million - $26.1 Million	1,250,001 New	1,250,001 $19.8 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.